Bafna Pharmaceuticals Ltd
Bafna Pharma. | 532989
Stock Performance
Ratios
About Company
- Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr
- Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products
- The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p
- Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p
- and then liquid line with an installed capacity of 45000 lts p
- Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern
- During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products
- During 2006, Bafna has set up a 100% EOU unit at Madhavaram for the production of tablets and capsule with a capacity of 6973
- This facility has been set up as per revised Schedule M under the Drugs and Cosmetics Act, 1947
- The unit has been WHO GMP certified and also ISO 9000 certified
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Frequently Asked Questions
What is Share Price of Bafna Pharmaceuticals Ltd?
The current share price of Bafna Pharmaceuticals Ltd (Bafna Pharma.) is ₹177.54. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Bafna Pharmaceuticals Ltd?
The Price-to-Earnings (P/E) ratio of Bafna Pharmaceuticals Ltd is 177.54. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Bafna Pharmaceuticals Ltd?
Bafna Pharmaceuticals Ltd has a 52-week high of ₹202.06 and a 52-week low of ₹69.00. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Bafna Pharmaceuticals Ltd?
Bafna Pharmaceuticals Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Bafna Pharmaceuticals Ltd?
The Earnings Per Share (EPS) of Bafna Pharmaceuticals Ltd is ₹-0.92. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Bafna Pharmaceuticals Ltd?
Bafna Pharmaceuticals Ltd has a Return on Equity (ROE) of 4.98%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
